Description:[001] The present invention relates generally to the field of medical image analysis and artificial intelligence. More particularly, it pertains to a novel heuristic-driven artificial intelligence framework for the automated classification and segmentation of brain tumor images obtained from medical imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET). The invention combines data-driven deep learning approaches with domain-specific heuristic rules to enhance diagnostic accuracy, interpretability, and clinical usability in brain tumor detection and analysis.
BACKGROUND OF THE INVENTION
[002] Brain tumors are among the most severe neurological disorders, often resulting in life-threatening conditions if not diagnosed and treated at an early stage. Accurate and timely detection of brain tumors plays a critical role in guiding therapeutic decisions, monitoring disease progression, and improving patient outcomes.
[003] Medical imaging techniques, such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET), are widely used for brain tumor detection and evaluation. These imaging modalities provide high-resolution visual representations of brain structures, enabling radiologists to identify abnormalities and tumor regions.
[004] Traditionally, tumor detection and segmentation are performed manually by radiologists, who visually examine the images and delineate the tumor boundaries. However, this process is time-consuming, prone to fatigue, and subject to inter-observer variability. Even experienced clinicians may arrive at inconsistent conclusions due to the complex and irregular morphology of tumors.
[005] Automated image analysis methods have been developed to assist clinicians in identifying brain tumors. Early techniques employed conventional image processing algorithms such as edge detection, thresholding, and clustering. While these approaches provide some level of automation, they often fail to generalize across heterogeneous datasets, resulting in poor accuracy when faced with variations in tumor size, shape, and imaging conditions.
[006] With the rise of machine learning and deep learning techniques, significant improvements have been achieved in tumor classification and segmentation. Convolutional Neural Networks (CNNs), U-Nets, and attention-based models have shown promising results in detecting tumors with high accuracy. However, these methods require large annotated datasets for training and involve computationally expensive operations that limit their scalability in clinical environments.
[007] A major drawback of existing deep learning approaches is their “black-box” nature, which lacks transparency and interpretability. Radiologists often demand explainable reasoning for diagnostic outcomes, but current models fail to provide insight into why a particular prediction was made. This lack of interpretability reduces trust in AI systems and hinders their widespread adoption in clinical practice.
[008] Furthermore, current solutions are sensitive to noise, imaging artifacts, and variations in acquisition protocols. For example, differences in MRI machine settings or patient demographics can significantly affect prediction performance. Without adaptability, deep learning models risk producing false positives or false negatives, which could adversely impact treatment decisions.
[009] Another limitation of existing systems is the absence of heuristic or domain-specific rules that could complement deep learning predictions. Radiologists often rely on contextual knowledge—such as brain symmetry, tumor growth patterns, and intensity profiles—when making diagnostic decisions. Incorporating these heuristic rules into AI models can provide additional guidance, improving both robustness and interpretability.
[010] Therefore, there exists a need for a hybrid framework that integrates deep learning with heuristic-driven decision-making for brain tumor image analysis. Such a system would enhance classification and segmentation accuracy, reduce false detections, improve transparency, and provide radiologists with clinically relevant, explainable outputs that support effective treatment planning.
SUMMARY OF THE INVENTION
[011] The present invention provides an Artificial Intelligence-Based Heuristic Framework for Classification and Segmentation of Brain Tumor Images, which overcomes the limitations of existing image analysis techniques. The invention integrates the strengths of deep learning models with heuristic decision-making rules, enabling accurate, explainable, and clinically adaptable tumor classification and segmentation.
[012] The proposed framework is designed as a multi-stage pipeline consisting of preprocessing, heuristic-guided feature extraction, tumor classification, tumor segmentation, and decision-support visualization. Unlike conventional methods, the invention employs heuristic rules—such as brain symmetry analysis, growth-pattern estimation, and intensity distribution heuristics—to dynamically guide and refine AI predictions.
[013] In the classification stage, the framework utilizes hybrid deep learning architectures, including convolutional and attention-based networks, to categorize tumor types such as gliomas, meningiomas, and pituitary tumors. The heuristic layer interacts with the deep model by adjusting thresholds and validating predictions against domain-specific rules, thereby enhancing accuracy and reducing false positives.
[014] For segmentation, the framework incorporates advanced architectures such as U-Net or Transformer-based networks. The heuristic rules act as constraints to ensure that segmentation outcomes adhere to anatomical boundaries, morphological expectations, and intensity consistency. This dual-layer approach significantly improves the reliability and interpretability of the segmentation results.
[015] An additional innovation of the invention lies in its explainability feature. Each AI-based decision is supported with heuristic reasoning, allowing the system to provide clinically relevant explanations, such as “tumor detected due to asymmetric intensity deviation in left hemisphere.” This improves clinician trust and facilitates adoption in diagnostic workflows.
[016] The invention further provides adaptability to heterogeneous imaging datasets, patient demographics, and acquisition protocols. By incorporating heuristics into the pipeline, the system can dynamically adjust to variations in imaging devices, resolutions, and conditions without extensive retraining, making it highly scalable for real-world hospital environments.
[017] Implementation of the system can be carried out on GPU-accelerated devices, cloud-based medical imaging platforms, or integrated hospital PACS systems. The framework supports real-time processing, automated reporting, and integration with electronic health records for seamless clinical use.
[018] Overall, the invention offers a robust, transparent, and clinically relevant solution for brain tumor image analysis. It addresses the shortcomings of prior art by reducing dependency on large datasets, minimizing false predictions, and delivering explainable outcomes that support radiologists in diagnosis and treatment planning.
BRIEF DESCRIPTION OF THE DRAWINGS
[019] The accompanying figures included herein, and which form parts of the present invention, illustrate embodiments of the present invention, and work together with the present invention to illustrate the principles of the invention Figures:
[020] Figure 1, illustrates the system architecture of the proposed Artificial Intelligence-Based Heuristic Framework for Classification and Segmentation of Brain Tumor Images.
[021] Figure 2, illustrates the workflow of the heuristic-guided AI pipeline for brain tumor analysis.
DETAILED DESCRIPTION OF THE INVENTION
[022] The present invention provides a novel Artificial Intelligence-Based Heuristic Framework for Classification and Segmentation of Brain Tumor Images, which integrates deep learning with domain-specific heuristics to enhance accuracy, interpretability, and clinical relevance. The framework is modular, scalable, and adaptable to heterogeneous datasets and imaging modalities, such as MRI, CT, and PET.
[023] Data Acquisition and Preprocessing: Brain tumor images are acquired from standard medical imaging devices. The preprocessing module performs operations including noise reduction (e.g., Gaussian filtering, anisotropic diffusion), intensity normalization, and skull stripping to isolate brain tissues. Additional preprocessing may include contrast enhancement and resizing to standard dimensions suitable for AI model input. These operations ensure uniformity across diverse datasets and minimize artifacts that could impact subsequent analysis.
[024] Heuristic-Guided Feature Extraction: A key innovation of the invention is the incorporation of heuristic rules derived from medical domain knowledge. These rules capture clinically relevant patterns such as asymmetry in hemispheres, intensity deviation corresponding to abnormal tissue, tumor growth directionality, and shape irregularities. Feature extraction involves computing statistical measures, morphological parameters, and spatial characteristics guided by these heuristics. These features are then fed into the classification and segmentation models alongside the raw image data.
[025] Classification Module: The classification stage employs a hybrid deep learning model combining Convolutional Neural Networks (CNNs) and attention-based architectures. CNNs extract spatial features, while attention mechanisms highlight tumor regions and relevant features, improving the model’s focus and accuracy. The heuristic layer dynamically adjusts the model's thresholds and validates predictions against domain-specific rules. This integration reduces false positives and ensures that ambiguous cases are flagged for clinician review.
[026] Segmentation Module: Tumor segmentation is performed using U-Net or Transformer-based architectures. The segmentation network is guided by heuristic constraints, such as connectivity of tumor regions, intensity priors, and anatomical boundaries. Post-processing steps, informed by heuristics, remove false detections and refine tumor boundaries. This combination of AI-driven segmentation and heuristic validation ensures precise delineation of tumors, even in complex cases with heterogeneous intensity patterns.
[027] Explainability and Decision Support: The heuristic component provides transparent reasoning for AI predictions. For each classified or segmented tumor, the system can generate explanations linking detected patterns to specific heuristic rules, e.g., highlighting regions with asymmetric intensity deviations or abnormal morphological features. This explainability improves clinician trust, facilitates decision-making, and allows radiologists to validate AI outputs effectively.
[028] Adaptability to Heterogeneous Datasets: The invention is designed to operate effectively across various imaging modalities, patient demographics, and acquisition protocols. The heuristic rules enable dynamic adaptation to variations in image quality, intensity range, and anatomical differences, minimizing the need for extensive retraining. This makes the system robust and suitable for deployment in multiple hospital environments.
[029] System Implementation: The framework can be implemented on GPU-accelerated workstations, cloud-based platforms, or integrated into hospital PACS systems. Real-time processing capabilities allow rapid analysis of large image datasets. The system can generate automated reports, annotated segmentation outputs, and classification labels for clinical use, providing a seamless interface between AI predictions and physician workflows.
[030] Performance Improvements: By combining heuristic rules with deep learning, the system reduces false positives, increases segmentation accuracy, and improves classification performance compared to conventional AI approaches. The framework requires relatively smaller datasets than purely deep learning systems, due to the additional guidance provided by heuristics. This ensures efficient training and deployment in clinical environments with limited annotated data.
[031] Potential Extensions: The framework can be extended to multimodal imaging, such as combining MRI and PET for more accurate tumor characterization. Additionally, the heuristic-guided approach can be applied to other medical imaging applications, including lung, liver, and breast cancer detection, providing a generalizable AI solution for medical diagnostics.
[032] The invention provides a robust, explainable, and adaptable system for automated classification and segmentation of brain tumors. The integration of deep learning with heuristic rules ensures high diagnostic accuracy, clinical relevance, and improved trustworthiness for use in real-world medical environments.
[033] In conclusion, the present invention provides a comprehensive Artificial Intelligence-Based Heuristic Framework for Classification and Segmentation of Brain Tumor Images that integrates deep learning architectures with domain-specific heuristic rules. This hybrid approach enhances the accuracy, reliability, and explainability of tumor detection, addressing the limitations of conventional manual and purely AI-based methods. The framework ensures precise tumor segmentation, robust classification of tumor types, and provides clinicians with interpretable decision-support, improving diagnostic confidence and clinical outcomes.
[034] The invention significantly reduces false positives and improves generalization across heterogeneous datasets and diverse imaging modalities, including MRI, CT, and PET. By incorporating heuristic knowledge such as brain symmetry, intensity distributions, and tumor morphology, the system guides the AI models to produce clinically meaningful predictions, making it more suitable for real-world hospital environments and scalable across medical institutions.
[035] The future scope of the invention includes expanding the framework to multimodal imaging applications, where data from multiple imaging techniques (e.g., MRI combined with PET) can be fused for enhanced tumor characterization. Additionally, the system can be extended to incorporate longitudinal patient data, enabling prediction of tumor progression and personalized treatment planning.
[036] Beyond brain tumor analysis, the heuristic-driven framework can be adapted for other medical imaging domains, such as lung, liver, and breast cancer detection, as well as neurological disorders like stroke and multiple sclerosis. The combination of AI and heuristic reasoning provides a generalizable methodology for building explainable and clinically reliable diagnostic systems.
[037] Overall, the invention offers a robust, scalable, and clinically interpretable solution for automated brain tumor analysis. By seamlessly integrating AI with domain knowledge, it enhances decision-making, reduces diagnostic errors, and sets a foundation for future advancements in intelligent medical imaging systems.
, Claims:1. An artificial intelligence-based heuristic framework for classification and segmentation of brain tumor images, comprising preprocessing, heuristic-guided feature extraction, classification, segmentation, and decision-support modules.
2. The system of claim 1, wherein preprocessing includes noise reduction, intensity normalization, and skull stripping of medical images.
3. The system of claim 1, wherein heuristic rules encode brain symmetry, tumor intensity distribution, morphological characteristics, and tumor growth patterns.
4. The system of claim 1, wherein the classification module employs a hybrid deep learning model combining convolutional neural networks and attention-based mechanisms.
5. The system of claim 1, wherein the segmentation module utilizes U-Net or Transformer-based architectures guided by heuristic constraints.
6. The system of claim 1, wherein post-processing operations include heuristic-based refinement to eliminate false positives and improve tumor boundary delineation.
7. The system of claim 1, wherein the heuristic layer provides explainable reasoning for AI predictions to assist clinicians in decision-making.
8. The system of claim 1, wherein the framework adapts dynamically to heterogeneous imaging modalities, acquisition protocols, and patient demographics.
9. The system of claim 1, implemented on GPU-accelerated computing devices, cloud-based platforms, or integrated hospital PACS systems for real-time analysis.
10. The system of claim 1, wherein the framework is extendable to multimodal imaging applications and other medical diagnostic domains beyond brain tumors.